Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Vazalore Generic Name & Formulations
Legal Class
OTC
General Description
Aspirin 81mg, 325mg; liquid-filled caps; contains soy.
Pharmacological Class
Salicylate.
How Supplied
Caps 81mg—12, 30; 325mg—30
Manufacturer
Generic Availability
NO
Vazalore Indications
Indications
Arthritic and rheumatic conditions.
Vazalore Dosage and Administration
Adult
Rheumatoid arthritis, arthritis and pleurisy of SLE: initially 3g daily in divided doses; target plasma salicylate level 150–300mcg/mL. Osteoarthritis: up to 3g/day in divided doses. Spondyloarthropathies: up to 4g/day in divided doses.
Children
JRA: initially 90–130mg/kg per day in divided doses; target plasma salicylate level 150–300mcg/mL.
Vazalore Contraindications
Contraindications
NSAID allergy. Viral infection in children and teenagers.
Vazalore Boxed Warnings
Not Applicable
Vazalore Warnings/Precautions
Warnings/Precautions
History of asthma or peptic ulcer. Severe hepatic or renal dysfunction. Hypertension. Cardiovascular disease. Bleeding disorders. Diabetes. Gout. Arthritis. Labor & delivery. Pregnancy (esp. during ≥20 weeks): not recommended. Nursing mothers.
Vazalore Pharmacokinetics
See Literature
Vazalore Interactions
Interactions
Potentiates anticoagulants, hypoglycemics, methotrexate, acetazolamide, valproic acid, highly protein-bound drugs. Urinary alkalinizers, antacids, corticosteroids may increase excretion. May antagonize ACE inhibitors, β-blockers, diuretics, uricosurics. Increased bleeding risk with NSAIDs or chronic, heavy alcohol use (≥3 drinks/day). NSAIDs increase risk of renal dysfunction.
Vazalore Adverse Reactions
Adverse Reactions
GI upset/bleed, prolonged bleeding time, anaphylaxis, salicylism.
Vazalore Clinical Trials
See Literature
Vazalore Note
Not Applicable
Vazalore Patient Counseling
See Literature
Vazalore Generic Name & Formulations
Legal Class
OTC
General Description
Aspirin 81mg, 325mg; liquid-filled caps; contains soy.
Pharmacological Class
Salicylate.
How Supplied
Caps 81mg—12, 30; 325mg—30
Manufacturer
Generic Availability
NO
Vazalore Indications
Indications
Pain. Fever.
Vazalore Dosage and Administration
Adult
≥12yrs: 325–650mg every 4hrs or 975mg every 6hrs while symptoms persist; max 3900mg in 24hrs.
Children
<12yrs: consult a physician.
Vazalore Contraindications
Contraindications
NSAID allergy. Viral infection in children and teenagers.
Vazalore Boxed Warnings
Not Applicable
Vazalore Warnings/Precautions
Warnings/Precautions
History of asthma or peptic ulcer. Severe hepatic or renal dysfunction. Hypertension. Cardiovascular disease. Bleeding disorders. Diabetes. Gout. Arthritis. Labor & delivery. Pregnancy (esp. during ≥20 weeks): not recommended. Nursing mothers.
Vazalore Pharmacokinetics
See Literature
Vazalore Interactions
Interactions
Potentiates anticoagulants, hypoglycemics, methotrexate, acetazolamide, valproic acid, highly protein-bound drugs. Urinary alkalinizers, antacids, corticosteroids may increase excretion. May antagonize ACE inhibitors, β-blockers, diuretics, uricosurics. Increased bleeding risk with NSAIDs or chronic, heavy alcohol use (≥3 drinks/day). NSAIDs increase risk of renal dysfunction.
Vazalore Adverse Reactions
Adverse Reactions
GI upset/bleed, prolonged bleeding time, anaphylaxis, salicylism.
Vazalore Clinical Trials
See Literature
Vazalore Note
Not Applicable
Vazalore Patient Counseling
See Literature
Vazalore Generic Name & Formulations
Legal Class
OTC
General Description
Aspirin 81mg, 325mg; liquid-filled caps; contains soy.
Pharmacological Class
Antiplatelet.
How Supplied
Caps 81mg—12, 30; 325mg—30
Manufacturer
Generic Availability
NO
Vazalore Indications
Indications
To reduce combined risk of death and nonfatal stroke after ischemic stroke or TIA. To reduce risk of vascular mortality in suspected acute MI. To reduce combined risk of death and nonfatal MI after MI or unstable angina pectoris. To reduce combined risk of MI and sudden death in chronic stable angina. Revascularization procedures.
Vazalore Dosage and Administration
Adult
Ischemic stroke and TIA: 50–325mg once daily. Suspected acute MI: 160–162.5mg once daily (start as soon as MI suspected) then for at least 30 days post-MI. Prevention of recurrent MI, unstable angina pectoris, chronic stable angina: 75–325mg once daily. Coronary artery bypass graft: 325mg once daily (start 6hrs after procedure) for 1yr. Percutaneous transluminal coronary angioplasty: 325mg 2 hours before surgery, then 160–325mg once daily. Carotid endarterectomy: 80mg once daily to 650mg twice daily (start before surgery).
Children
Not recommended.
Vazalore Contraindications
Contraindications
NSAID allergy. Viral infection in children and teenagers.
Vazalore Boxed Warnings
Not Applicable
Vazalore Warnings/Precautions
Warnings/Precautions
History of asthma or peptic ulcer. Severe hepatic or renal dysfunction. Hypertension. Cardiovascular disease. Bleeding disorders. Diabetes. Gout. Arthritis. Labor & delivery. Pregnancy (esp. during ≥20 weeks): not recommended. Nursing mothers.
Vazalore Pharmacokinetics
See Literature
Vazalore Interactions
Interactions
Potentiates anticoagulants, hypoglycemics, methotrexate, acetazolamide, valproic acid, highly protein-bound drugs. Urinary alkalinizers, antacids, corticosteroids may increase excretion. May antagonize ACE inhibitors, β-blockers, diuretics, uricosurics. Increased bleeding risk with NSAIDs or chronic, heavy alcohol use (≥3 drinks/day). NSAIDs increase risk of renal dysfunction.
Vazalore Adverse Reactions
Adverse Reactions
GI upset/bleed, prolonged bleeding time, anaphylaxis, salicylism.
Vazalore Clinical Trials
See Literature
Vazalore Note
Not Applicable
Vazalore Patient Counseling
See Literature
